USA. Some Roadblocks to Lifesaving Addiction Treatment Are Gone. Now What?

For two decades — as opioid overdose deaths rose steadily — the federal government limited access to buprenorphine, a medication that addiction experts consider the gold standard for treating patients with opioid use disorder. Study after study shows it helps people continue addiction treatment while reducing the risk of overdose and death.

Clinicians who wanted to prescribe the medicine had to complete an eight-hour training. They could treat only a limited number of patients and had to keep special records. They were given a Drug Enforcement Administration registration number starting with X, a designation many doctors say made them a target for drug-enforcement audits.

“Just the process associated with taking care of our patients with a substance use disorder made us feel like, ‘Boy, this is dangerous stuff,'” said Dr. Bobby Mukkamala, who chairs an American Medical Association task force addressing substance use disorder. 

“The science doesn’t support that but the rigamarole suggested that.” (KHN – Kaiser Health News, USA, 21.03.2023)

https://khn.org/news/article/some-roadblocks-to-lifesaving-addiction-treatment-are-gone-now-what/